These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24791374)

  • 1. Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.
    Rajpurohit N; Aryal SR; Khan MA; Stys AT; Stys TP
    S D Med; 2014 Apr; 67(4):137-9. PubMed ID: 24791374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting propafenone toxicity.
    Alsaad AA; Ortiz Gonzalez Y; Austin CO; Kusumoto F
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28446489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cardiac toxicity following alcohol intake in a patient using therapeutic dose of propafenone.
    Bayram Z; Güner A; Doğan C; Yılmaz F; Özdemir N
    Turk Kardiyol Dern Ars; 2017 Dec; 45(8):752-754. PubMed ID: 29226898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncope, widened QRS interval, and left ventricular systolic depression: coincident with propafenone therapy for atrial fibrillation.
    Samaan RA; Sobamowo HO; Tamburrino F; Grodman R; Isber N
    Tex Heart Inst J; 2010; 37(4):476-9. PubMed ID: 20844627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLMD-like nocturnal movements with mirtazapine.
    Mattoo SK; Mahajan S; Sarkar S; Nebhinani N
    Gen Hosp Psychiatry; 2013; 35(5):576.e7-8. PubMed ID: 23273829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute propafenone toxicity after two exposures at standard dosing.
    Yeung A; Shanks D; Parwana H; Gin K
    Can J Cardiol; 2010; 26(6):209-10. PubMed ID: 20548984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].
    Martínez-Sellés M; Castillo I; Montenegro P; Martín ML; Almendral J; Sanjurjo M
    Rev Esp Cardiol; 2005 Jun; 58(6):745-8. PubMed ID: 15970126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Persistent atrial flutter induced by propafenone (Rytmonorm)].
    Fazekas T; Kiss J; Pap I; Rudas L
    Orv Hetil; 1994 Aug; 135(33):1819-22. PubMed ID: 8072758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure.
    La Rocca R; Ferrari-Toninelli G; Patanè S
    Int J Cardiol; 2014 Nov; 177(1):57-60. PubMed ID: 25499340
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation: adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction.
    Boriani G; Biffi M; Diemberger I; Domenichini G; Marziali A; Martignani C
    Int J Cardiol; 2010 Apr; 140(2):242-3; author reply 243-4. PubMed ID: 19062111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akathisia induced by mirtazapine after 20 years of continuous treatment.
    Markoula S; Konitsiotis S; Chatzistefanidis D; Lagos G; Kyritsis AP
    Clin Neuropharmacol; 2010; 33(1):50-1. PubMed ID: 20124786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
    Fusar-Poli P; Matteo L; Luca de M; Politi P; Cortesi M; Carboni V
    J Psychosom Res; 2007 Jan; 62(1):101. PubMed ID: 17188127
    [No Abstract]   [Full Text] [Related]  

  • 14. Mirtazapine-induced hepatotoxicity.
    Hui CK; Yuen MF; Wong WM; Lam SK; Lai CL
    J Clin Gastroenterol; 2002 Sep; 35(3):270-1. PubMed ID: 12192206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone-induced ataxia: report of three cases.
    Odeh M; Seligmann H; Oliven A
    Am J Med Sci; 2000 Aug; 320(2):151-3. PubMed ID: 10981493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of propafenone after long-term therapy with the addition of citalopram.
    Garcia A
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):96-9. PubMed ID: 18675768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    Wiesfeld AC; Ansink JM; van Veldhuisen DJ; van Gelder IC
    Int J Cardiol; 2006 Feb; 107(1):140-1. PubMed ID: 15990183
    [No Abstract]   [Full Text] [Related]  

  • 18. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
    Stimmel GL; Dopheide JA; Stahl SM
    Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proarrhythmic effects of propafenone in a woman with hepatopathy: is it always a simple drug in clinical practice?].
    Hrovatin E; Piazza R; Brieda M; Dametto E; Zardo F; Burelli C; Cassin M; Nicolosi GL
    Ital Heart J Suppl; 2002 Jul; 3(7):770-5. PubMed ID: 12187639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.